ReviewReports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology2025
Magnetic resonance-guided adaptive stereotactic radiotherapy in prostate cancer patients: a systematic literature review.
Review in Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- MRI-guided adaptive stereotactic body radiotherapy for the prostate bed: a prospective study of safety, tolerability, and patient-reported quality-of-life outcomes.Clinical and translational radiation oncology · 2026Article
- MR-Linac-Based SBRT for Prostate Cancer: Dosimetric Benefits for Urethral Sparing Compared to VMAT and Tomotherapy.Cancers · 2026Article
- Impact of Adaptive Radiation Therapy on Toxicity in Prostate Cancer: A Scoping Review.Biomedicines · 2026Review
- The optimal approach to the primary treatment of uveal melanoma: a narrative review.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Magnetic resonance-guided adaptive stereotactic radiotherapy (MRgRT) represents an innovative approach in radiation oncology, combining real-time MR imaging with treatment delivery systems. This systematic literature review evaluates the efficacy, safety, and technical aspects of MRgRT in prostate cancer treatment compared to conventional radiotherapy approaches. Materials and methods: A systematic search was conducted across PubMed, Embase, and Scopus databases following PRISMA guidelines. Randomized clinical trials, prospective cohort studies, and relevant retrospective studies published through 2024, evaluating MRgRT in primary or recurrent prostate cancer treatment, were included. Risk of bias was assessed using the Cochrane RoB 2 tool for randomized trials and ROBINS-I tool for non-randomized studies. Data regarding acute and late toxicity, biochemical control, and technical aspects of treatment were analyzed through qualitative synthesis. Results: The pivotal MIRAGE randomized trial (n = 156) demonstrated significant toxicity reduction in the MRgRT group compared to CT-guided radiotherapy (grade ≥ 2 GU toxicity: 24.4% Conclusions: MRgRT represents a breakthrough technology in prostate cancer radiotherapy, enabling significant reduction in treatment toxicity while maintaining high precision in dose delivery. Results of ultra-hypofractionated regimens are particularly promising. Further studies are needed to evaluate long-term treatment outcomes and cost-effectiveness of this method.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.